c-Mesenchymal-Epithelial Transition (cMet)
Showing 1 - 25 of >10,000
Long Non-coding RNA in Process of Epithelial-mesenchymal
Active, not recruiting
- Periodontal Disease, AVDC Stage 3and 4
- +2 more
- periodontitis challenge
-
Baghdad, Iraqsaif mohammed T AL Mufti
Aug 8, 2023
Epithelial-Mesenchymal Transition Associated Markers in
Recruiting
- Peri-implantitis
-
Karbala, IraqTalib A. Alnajaty
Apr 14, 2023
Epithelial Mesenchymal Transition and Periodontitis
Recruiting
- Periodontitis
- +5 more
- Modified Widman flap
- Gingivectomy
-
Baghdad, IraqCollege of Dentistry, University of Baghdad
May 30, 2022
Moesin Expression in Clear Cell Renal Cell Carcinoma
Completed
- Renal Cell Carcinoma
- Immunohistochemical detection of Moesin in Clear cell Renal Cell Carcinoma
- (no location specified)
Sep 20, 2023
Triple Negative Breast Cancer, Chemo Effect, Simvastatin Adverse Reaction Trial in Jakarta Pusat (Simvastatin 40mg, Placebo)
Recruiting
- Triple Negative Breast Cancer
- +2 more
- Simvastatin 40mg
- Placebo
-
Jakarta Pusat, DKI Jakarta, IndonesiaDr. Cipto Mangunkusumo National Central General Hospital
Sep 22, 2022
Advanced Solid Tumors Trial in Goyang-si, Seoul (ABN401)
Not yet recruiting
- Advanced Solid Tumors
-
Goyang-si, Gyeonggi-Do, Korea, Republic of
- +2 more
Sep 13, 2022
Barrett's Esophagus, Gastroesophageal Reflux Disease Trial in Dallas (Cessation of Acid Suppressing Medications)
Enrolling by invitation
- Barrett's Esophagus
- Gastroesophageal Reflux Disease
- Cessation of Acid Suppressing Medications
-
Dallas, TexasDallas VA Medical Center
Aug 16, 2021
EMT on CTCs and Disease Progression in Prostate Cancer
Active, not recruiting
- Prostate Cancer
- CellSearch CTC platform
- Parsortix CTC platform
-
London, Ontario, CanadaLondon Regional Cancer Program
Mar 5, 2022
EMT in Peritoneal Dialysis Patients
Completed
- Peritoneal Dialysis Complication
- Isolation of peritoneal mesothelial cells
-
Aurora, ColoradoUniversity of Colorado Anschutz Medical Campus
Feb 23, 2021
Investigate eNAMPT in Multiple Myeloma Biology and Establish Its
Recruiting
- Multiple Myeloma
-
Torino, TO, ItalyAou Citta' Della Salute E Della Scienza Di Torino
Aug 17, 2021
Specific Protein Overexpression in Adult Non-Small Cell Lung
Not yet recruiting
- Non Small Cell Lung Cancer
- (no location specified)
Sep 29, 2023
NSCLC Trial in Worldwide (Capmatinib, Amivantamab)
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
-
Orange, California
- +40 more
Aug 3, 2022
Lung Cancer, Non Small Cell Lung Cancer Trial in Aurora (Amivantamab 1050mg, Amivantamab 1400mg, Amivantamab (to be determined))
Not yet recruiting
- Lung Cancer
- Non Small Cell Lung Cancer
- Amivantamab 1050mg
- +2 more
-
Aurora, Colorado
- +2 more
Apr 25, 2023
NSCLC Trial in Worldwide (Tepotinib, Osimertinib)
Active, not recruiting
- Non-small Cell Lung Cancer
-
Yuma, Arizona
- +178 more
Dec 19, 2022
Colorectal Tumors Trial in Worldwide (Tepotinib, Cetuximab)
Active, not recruiting
- Colorectal Neoplasms
- Tepotinib
- Cetuximab
-
Phoenix, Arizona
- +66 more
Nov 19, 2021
CTC, Free DNA, Stem Cells and EMT-related Antigens as Biomarkers
Active, not recruiting
- Prostate Cancer
- +3 more
- blood and FFPE sample collection
-
Ancona, AN, Italy
- +8 more
Feb 25, 2021
Epithelial-to-mesenchymal Transition in Breast Cancer Lymph
Unknown status
- Breast Cancer
- Lymph Node Metastases
-
Beijing, Beijing, ChinaPeking university people's hospital
Oct 22, 2019
Chronic Rhinosinusitis With Nasal Polyps, Chronic Rhinosinusitis (Diagnosis) Trial (Mepolizumab)
Not yet recruiting
- Chronic Rhinosinusitis With Nasal Polyps
- Chronic Rhinosinusitis (Diagnosis)
- (no location specified)
May 30, 2023
Met Non Small Cell Cancer Registry (MOMENT)
Recruiting
- Cancer
-
Fort Lauderdale, Florida
- +53 more
Nov 3, 2022
Bronchiolitis Obliterans Trial (Study morphological and functional of respiratory epithelium)
Not yet recruiting
- Bronchiolitis Obliterans
- Study morphological and functional of respiratory epithelium
- (no location specified)
Nov 20, 2023
Metastatic Triple-Negative Breast Carcinoma Trial in Singapore (Bexarotene, Capecitabine)
Recruiting
- Metastatic Triple-Negative Breast Carcinoma
-
Singapore, SingaporeNational Cancer Center Singapore
Jun 10, 2022
NSCLC Trial in Japan, Korea, Republic of, Singapore (capmatinib, pemetrexed, cisplatin)
Terminated
- Carcinoma, Non-Small-Cell Lung
- capmatinib
- +4 more
-
Kashiwa, Chiba, Japan
- +3 more
Jan 31, 2023